Cost-effectiveness analysis of two inhaled antibiotics for stable Bronchiectasis with Pseudomonas aeruginosa infections in China
TIS reduces healthcare costs and improves clinical outcomes compared to CMS in managing BE with PA infections in China. This study supports the inclusion of TIS in clinical guidelines for managing BE with PA infections, considering both economic benefits and health outcomes.
Authors
- Wanjun Li (ORCID: https://orcid.org/0000-0003-4707-4288)
- Wanxin Chen (ORCID: https://orcid.org/0000-0001-7049-9589)
- Canghong Zhi
- Sha Li
- Liting Lai
- Jie Jiang (ORCID: https://orcid.org/0000-0002-5973-7010)
- Xuerong Chen (ORCID: https://orcid.org/0000-0003-3792-8243)
- Bin Na Hong (ORCID: https://orcid.org/0000-0002-4186-4433)
Institutions
- Jinan University (CN)
- China National Pharmaceutical Group Corporation (China) (CN)
- Zhangzhou Municipal Hospital of Fujian Province (CN)
- 175th Hospital of People's Liberation Army (CN)
- Zhangzhou Vocational and Technical College (CN)
- Shenzhen Third People’s Hospital (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1371/journal.pone.0324254
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00